OmniAb, Inc. (OABI) Stock Forecast

NASDAQ: OABIAnalyst ratings, price target and estimates.

OABI analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
5.00 / 5 from 7 analysts
Price target
$8.33
average of analyst targets
Upside to target
+81.6%
from the latest close
Next earnings
October 30, 2026
EPS estimate $-0.12
52-week range
$1.36 – $5.04

OABI analyst ratings

7 analysts
Strong buy
7100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

OABI price target

Price $4.59Target $8.33
52-week low $1.3652-week high $5.04

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

OABI earnings per share estimates

OmniAb, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.13−$0.14−$0.12−$0.14+7.1%4
Current fiscal year (2026)−$0.37−$0.39−$0.34−$0.57+35.8%5
Next fiscal year (2027)−$0.29−$0.42−$0.17−$0.37+20.1%4

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

OABI revenue estimates

OmniAb, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$3.5M$2.9M$3.9M+56.0%7
Current fiscal year (2026)$35.0M$33.0M$36.4M+87.7%7
Next fiscal year (2027)$43.9M$30.0M$68.0M+25.3%6

OABI EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

OABI revenue: reported and forecast

Reported revenueEstimate (average; low–high)

OABI EPS estimate revisions

OmniAb, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.12−$0.13−$0.13−$0.13−$0.13+10.6%1 up · 3 down
Current fiscal year (2026)−$0.42−$0.37−$0.37−$0.37−$0.37−12.0%5 up · 0 down
Next fiscal year (2027)−$0.32−$0.30−$0.29−$0.29−$0.29−9.3%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

OABI earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; OABI beat in 7 of 12.

What analysts expect from OABI

7 analysts cover OmniAb; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.33, 81.6% above the latest close of $4.59. Analysts expect earnings of −$0.37 per share for 2026, +35.8% from a year earlier. For 2027 the average estimate is −$0.29 per share on revenue of $43.9 million. OmniAb beat the EPS estimate in 7 of the last 12 quarters.

Related: OABI income statement, OABI key metrics, OABI chart. See the OABI stock overview for the latest quote and news.

OABI forecast FAQ

What is OmniAb's price target?

The average analyst price target for OmniAb is $8.33, 81.6% above the latest close of $4.59.

Is OmniAb a buy, hold or sell?

Of 7 analysts covering OmniAb, 7 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is OmniAb's EPS forecast?

Analysts forecast −$0.37 per share for 2026 (range −$0.39 to −$0.34); for 2027 the estimate is −$0.29.

What is OmniAb's revenue forecast?

The average revenue estimate for 2026 is $35.0 million, growth of 87.7%; for 2027 it is $43.9 million.

When does OmniAb report earnings?

OmniAb is expected to report results for the quarter ending September 30, 2026 on October 30, 2026 before the market opens; the EPS estimate is $-0.12.

Does OmniAb usually beat earnings estimates?

OmniAb reported EPS at or above the analyst estimate in 7 of the last 12 quarters.

Biotechnology: forecast